TipRanks
Advertisement
Advertisement

PCENARE Stock Latest News

ENA Respiratory Advances Phase IIa Study of INNA-051 Nasal Antiviral
Private CompaniesENA Respiratory Advances Phase IIa Study of INNA-051 Nasal Antiviral
19d ago
ENARE
ENA Respiratory Expands Asthma Clinical Program With Incubator Support
PremiumPrivate Companies
ENA Respiratory Expands Asthma Clinical Program With Incubator Support
1M ago
ENARE
ENA Respiratory Secures Funding for INNA-051 Asthma Clinical Study
PremiumPrivate Companies
ENA Respiratory Secures Funding for INNA-051 Asthma Clinical Study
1M ago
ENARE
ENA Respiratory Highlights Progress of INNA-051 and Industry Engagement at IPAC-RS
PremiumPrivate Companies
ENA Respiratory Highlights Progress of INNA-051 and Industry Engagement at IPAC-RS
1M ago
ENARE
ENA Respiratory Gains Visibility as INNA-051 Advances Through Phase 2a
PremiumPrivate Companies
ENA Respiratory Gains Visibility as INNA-051 Advances Through Phase 2a
1M ago
ENARE
ENA Respiratory Strengthens INNA-051 Clinical Momentum and Patent Protection
PremiumPrivate CompaniesENA Respiratory Strengthens INNA-051 Clinical Momentum and Patent Protection
4M ago
ENARE
ENA Respiratory Advances INNA-051 Phase IIa Study and Targets Partnering at BIO 2026
Premium
Private Companies
ENA Respiratory Advances INNA-051 Phase IIa Study and Targets Partnering at BIO 2026
4M ago
ENARE
ENA Respiratory Highlights Patent Portfolio Strength Around INNA-051 Program
Premium
Private Companies
ENA Respiratory Highlights Patent Portfolio Strength Around INNA-051 Program
4M ago
ENARE
ENA Respiratory Expands U.S. Patent Protection for TLR2 Respiratory Therapies
PremiumPrivate Companies
ENA Respiratory Expands U.S. Patent Protection for TLR2 Respiratory Therapies
4M ago
ENARE
ENA Respiratory Secures Key U.S. Patent Wins, Extending INNA-051 Commercial Runway to 2042+
PremiumPrivate Companies
ENA Respiratory Secures Key U.S. Patent Wins, Extending INNA-051 Commercial Runway to 2042+
4M ago
ENARE
ENA Respiratory Advances INNA-051 Trial And Highlights Strong Antiviral Demand Signals
PremiumPrivate Companies
ENA Respiratory Advances INNA-051 Trial And Highlights Strong Antiviral Demand Signals
5M ago
ENARE
Survey Engagement and Phase II Trial Spotlight Potential Demand for ENA Respiratory’s INNA-051
PremiumPrivate Companies
Survey Engagement and Phase II Trial Spotlight Potential Demand for ENA Respiratory’s INNA-051
5M ago
ENARE
Survey Data and ATS Presentation Spotlight ENA Respiratory’s Antiviral Focus
PremiumPrivate CompaniesSurvey Data and ATS Presentation Spotlight ENA Respiratory’s Antiviral Focus
5M ago
ENARE
ENA Respiratory Advances INNA-051 Phase IIa Trial for Respiratory Virus Prophylaxis
Premium
Private Companies
ENA Respiratory Advances INNA-051 Phase IIa Trial for Respiratory Virus Prophylaxis
5M ago
ENARE
ENA Respiratory Advances Phase IIa Trial of INNA-051 for Respiratory Virus Prevention
Premium
Private Companies
ENA Respiratory Advances Phase IIa Trial of INNA-051 for Respiratory Virus Prevention
5M ago
ENARE
ENA Respiratory Advances INNA-051 Into Larger Phase IIa Study After Positive Safety Review
PremiumPrivate Companies
ENA Respiratory Advances INNA-051 Into Larger Phase IIa Study After Positive Safety Review
5M ago
ENARE
ENA Respiratory – Weekly Recap
PremiumPrivate Companies
ENA Respiratory – Weekly Recap
5M ago
ENARE
ENA Respiratory Strengthens Board With Experienced Respiratory Dealmaker
PremiumPrivate Companies
ENA Respiratory Strengthens Board With Experienced Respiratory Dealmaker
5M ago
ENARE
ENA Respiratory Strengthens Board With Experienced Respiratory Deal-Maker
PremiumPrivate Companies
ENA Respiratory Strengthens Board With Experienced Respiratory Deal-Maker
5M ago
ENARE
ENA Respiratory Adds Veteran Dealmaker to Board as INNA-051 Advances in Clinic
PremiumPrivate CompaniesENA Respiratory Adds Veteran Dealmaker to Board as INNA-051 Advances in Clinic
5M ago
ENARE
ENA Respiratory Launches Phase II Community Trial of INNA-051 Nasal Antiviral in North America
Premium
Private Companies
ENA Respiratory Launches Phase II Community Trial of INNA-051 Nasal Antiviral in North America
8M ago
ENARE

Trending

Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >